Le Lézard
Classified in: Health
Subject: NPT

Omaha Healthcare Company Fusion Announces Nursing Scholarship Winners


OMAHA, Neb., May 9, 2024 /PRNewswire/ -- Omaha-based healthcare company Fusion is announcing the 10 winners of the Compassion in Care ? A Fusion Scholarship, aiming to assist students pursuing their Bachelor of Science in nursing. The 10 recipients will be awarded $5,000, renewable for up to four years, and have been matched with a Fusion mentor who will guide them as they attend nursing school.

"We had dozens of amazing applicants for this year's scholarship, which makes it tough for our internal committee to pick the winners, but it's exciting to have a glimpse into what the future of nursing looks like," said Chief Clinical Officer Amber Barna, MSN, RN. "Fusion's clinical team is excited to mentor the scholarship recipients and support them as they take on a selfless career."

The 2024 recipients include Brian Krewson of Malvern, Iowa; Cara Goodman of Hamburg, Iowa; Kylie Wesack of Council Bluffs, Iowa; Chiara Richeson of Fremont, Nebraska; Isabella Ramsgard of Omaha, Nebraska; Caitlin Linardos of Bradley, Maine; Alexis Honeyman of Omaha, Nebraska; Gracy Holys of Columbus, Nebraska; Madelyn Daino of Spring Lake, New Jersey; and Olivia Gardner of Council Bluffs, Iowa.

Fusion and its two business units, Fusion Medical Staffing and Fusion Workforce Solutions, exist to match clinicians to facilities needing their assistance while carrying out the core purpose of improving the lives of everyone the company touches. Fusion created the Compassion in Care scholarship to alleviate the burden of tuition costs and allow students to focus on their studies and clinical experience.

Learn more about Compassion in Care ? A Fusion Scholarship at workwithfusion.com/impact. Applications for next year will open in November.

About Fusion:

Fusion is an Omaha-based healthcare company that exists to create meaningful connections between healthcare travelers and facilities that lead to better patient care and better outcomes for all. The company consists of two business units: Fusion Medical Staffing and Fusion Workforce Solutions, which simplify processes for healthcare travelers and facilities at every turn. Fusion employees strive to stay humble, driven, and positive.

Media Contact:

Leah Kemple

4025755625

[email protected]

SOURCE Fusion


These press releases may also interest you

at 04:45
ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited (?ERS'), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS' CRISPR/Cas9 patent portfolio....

at 03:15
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
New Research by Tea Advisory Panel Reveals That Three Quarters Of Brits Never Drink Tea Before A Workout Despite It Counting Towards Fluid Intake Recommendations
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

More news about Health...


News published on and distributed by: